- Preamble [SYSTEM]
- Fund & Investor Interest
- Street Moves
- Solebury Trout Updates
- Market Commentary
- IPO News
- Expert Interactions
- Banker Comments & Notes
- Conference Snippet
- Industry Snippets
- Social Media
- Solebury Trout Talks

IPO News: Repare Therapeutics File $100mm IPO
Repare Therapeutics
Repare Therapeutics Inc.
NASDAQ: RPTX
Size: $100mm
Bookrunners: MS | GS | COWEN | PIPR
Major Holders: Versant | MPM | Orbimed | UBS Oncology Impact Fund | Cowen
Description: Repare is a precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics
Reference Link: S-1